Web30 aug. 2024 · Medtronic adds cardiac mapping platform through Affera acquisition 30th August 2024 2456 Medtronic has announced that it has completed the acquisition of Affera. The acquisition will expand Medtronic’s cardiac ablation portfolio to include its first cardiac mapping and navigation platform. Web30 aug. 2024 · Medtronic completes acquisition of Affera News provided by Medtronic plc Aug 30, 2024, 08:00 ET Acquisition adds mapping and navigation platform to …
Allison Kyriagis on LinkedIn: Medtronic completes acquisition of Affera
Web30 aug. 2024 · Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it has completed the acquisition of Affera, Inc. This acquisition … Web11 jan. 2024 · Medical device company Medtronic plc. ( NYSE:MDT) recently revealed that it has entered into a definitive agreement to acquire Affera, a medical technology … how to improve shooting skills in basketball
Medtronic concludes final treatment in Sphere-9 ablation …
Web6 dec. 2024 · The participants will be evaluated for 12 months for safety and efficacy. Medtronic Cardiovascular Portfolio Cardiac Ablation Solutions business president Rebecca Seidel said: “Treating the final patient in the fast-moving SPHERE Per-AF Trial builds on the exciting phase of innovation and growth at Medtronic over the last year, including the … Web30 aug. 2024 · Acquisition adds mapping and navigation platform to company's cardiac ablation portfolio and brings an integrated system of diagnostic and … Web11 jan. 2024 · However, Medtronic expects the acquisition to close in the first half of the company’s fiscal 2024, ... In such a scenario, the impending Affera acquisition claims to reduce the burden of AF. how to improve sharepoint